New York State Teachers Retirement System Has $11.33 Million Holdings in Revvity Inc. (NYSE:RVTY)

New York State Teachers Retirement System reduced its holdings in shares of Revvity Inc. (NYSE:RVTY - Free Report) by 4.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 107,068 shares of the company's stock after selling 4,501 shares during the period. New York State Teachers Retirement System owned about 0.09% of Revvity worth $11,328,000 at the end of the most recent reporting period.

Several other institutional investors have also made changes to their positions in the business. Assetmark Inc. boosted its stake in Revvity by 3,700.0% in the 4th quarter. Assetmark Inc. now owns 266 shares of the company's stock valued at $30,000 after buying an additional 259 shares in the last quarter. Optiver Holding B.V. acquired a new position in Revvity during the 4th quarter valued at about $33,000. Quarry LP lifted its position in Revvity by 45.7% during the 4th quarter. Quarry LP now owns 303 shares of the company's stock valued at $34,000 after purchasing an additional 95 shares during the period. Millstone Evans Group LLC acquired a new position in Revvity during the 4th quarter valued at about $38,000. Finally, Vermillion Wealth Management Inc. acquired a new position in Revvity during the 4th quarter valued at about $41,000. 86.65% of the stock is currently owned by institutional investors and hedge funds.

Revvity Stock Up 0.4%

Shares of NYSE RVTY traded up $0.41 during mid-day trading on Friday, reaching $101.31. 811,002 shares of the company's stock were exchanged, compared to its average volume of 972,715. The firm has a market capitalization of $11.94 billion, a price-to-earnings ratio of 43.11, a PEG ratio of 2.56 and a beta of 0.98. The company has a current ratio of 3.58, a quick ratio of 2.99 and a debt-to-equity ratio of 0.41. The business has a fifty day simple moving average of $94.04 and a 200 day simple moving average of $104.87. Revvity Inc. has a twelve month low of $87.70 and a twelve month high of $129.50.

Revvity (NYSE:RVTY - Get Free Report) last released its quarterly earnings results on Monday, April 28th. The company reported $1.01 EPS for the quarter, topping analysts' consensus estimates of $0.96 by $0.05. The company had revenue of $664.76 million for the quarter, compared to analyst estimates of $662.30 million. Revvity had a return on equity of 7.73% and a net margin of 10.35%. Revvity's revenue was up 2.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.98 earnings per share. As a group, equities analysts expect that Revvity Inc. will post 4.94 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 8th. Investors of record on Friday, July 18th will be issued a dividend of $0.07 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.28%. Revvity's payout ratio is 11.91%.

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on RVTY. Raymond James Financial restated an "outperform" rating and issued a $120.00 price objective (down from $145.00) on shares of Revvity in a report on Tuesday, April 29th. The Goldman Sachs Group cut their price target on Revvity from $140.00 to $125.00 and set a "buy" rating on the stock in a research note on Tuesday, April 29th. Wells Fargo & Company cut their price target on Revvity from $130.00 to $102.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 17th. UBS Group raised Revvity from a "neutral" rating to a "buy" rating and cut their price target for the company from $145.00 to $115.00 in a research note on Thursday, May 1st. Finally, JPMorgan Chase & Co. cut their target price on Revvity from $120.00 to $100.00 and set a "neutral" rating on the stock in a research note on Tuesday, April 29th. Four investment analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $123.64.

Revvity Company Profile

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.